Most recent by Carlos Buznego, MD
Extreme surgical challenges can spark creativity
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.
Glaucoma detection key to MIGS success
I am a comprehensive ophthalmologist practicing at the Center for Excellence in Eye Care, a subspecialty ophthalmology group in Miami. Given our location, we see a high proportion of minority patients from the Caribbean.
Perspective: Carlos Buznego, MD, on recent Glaukos data
The iStent infinite is under evaluation in an investigational device exemption FDA trial as a MIGS device that is performed independent of cataract surgery.
Patient type, surgeon comfort level help guide glaucoma surgery choice
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.
VIDEO: Safety, speed of visual recovery guide MIGS device choice
WAILEA, Hawaii — At Hawaiian Eye 2018, Carlos Buznego, MD, discusses how he selects which MIGS device to use at the time of cataract surgery.
MIGS at 4 years: Where are we now and where are we going?
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.